Mineralys Therapeutics reported net income of -$241.07M for the quarter ended Jun 2026. This income statement covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 5.61M | 5.61M | 5.18M | 5.17M | 24.76M | 40.86M | 41.11M | 41.13M | 49.63M | 49.71M | 49.76M | 49.82M | 53.16M | 65.73M | 78.97M | 67.66M | 82.45M | 88.35M |
| Operating items | ||||||||||||||||||
| Research & DevelopmentR&D | 6.78M | 5.59M | 6.06M | 7.82M | 12.29M | 11.88M | 22.50M | 23.68M | 30.75M | 39.27M | 53.98M | 44.57M | 37.88M | 38.28M | 31.45M | 24.40M | 24.36M | 221.38M |
| Selling, General & AdministrativeSG&A | 0.79M | 0.88M | 1.36M | 2.19M | 2.65M | 3.85M | 3.77M | 4.03M | 4.61M | 5.89M | 6.12M | 7.20M | 6.57M | 8.47M | 9.68M | 13.88M | 20.98M | 24.66M |
| Operating ExpensesOpex | 7.57M | 6.48M | 7.42M | 10.01M | 14.94M | 15.73M | 26.27M | 27.71M | 35.36M | 45.17M | 60.11M | 51.77M | 44.45M | 46.75M | 41.13M | 38.28M | 45.34M | 246.04M |
| Operating IncomeOp. Inc | -7.57M | -6.48M | -7.42M | -10.01M | -14.94M | -15.73M | -26.27M | -27.71M | -35.36M | -45.17M | -60.11M | -51.77M | -44.45M | -46.75M | -41.13M | -38.28M | -45.34M | -246.04M |
| EBIT | -7.57M | -6.48M | -7.42M | -10.01M | -14.94M | -15.73M | -26.27M | -27.71M | -35.36M | -45.17M | -60.11M | -51.77M | -44.45M | -46.75M | -41.13M | -38.28M | -45.34M | -246.04M |
| Non-operating items | ||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.74M | 0.94M | 2.33M | 3.59M | 3.51M | 3.32M | 3.85M | 4.15M | 3.77M | 2.81M | 2.24M | 3.47M | 4.20M | 6.04M | 6.00M | 4.96M | ||
| Other Non Operating IncomeOther Non Op Inc. | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | -0.01M | 0.01M | -0.00M | -0.00M | 0.00M | 0.00M | 0.01M | 0.01M | ||||
| Non Operating IncomeNon Op. Inc. | 0.74M | 0.94M | 2.33M | 3.59M | 3.51M | 3.32M | 3.85M | 4.15M | 3.76M | 2.82M | 2.24M | 3.47M | 4.20M | 6.05M | 6.00M | 4.97M | ||
| Net income details | ||||||||||||||||||
| EBT | -7.57M | -6.48M | -6.68M | -9.07M | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M | -41.02M | -56.33M | -48.96M | -42.21M | -43.27M | -36.94M | -32.23M | -39.34M | -241.08M |
| Profit After TaxPAT | -7.57M | -6.48M | -6.68M | -9.07M | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M | -41.01M | -56.34M | -48.95M | -42.21M | -43.27M | -36.93M | -32.28M | -39.34M | -241.07M |
| Income from Continuing OperationsIncome (Continuing) | -7.57M | -6.48M | -6.68M | -9.07M | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M | -41.02M | -56.33M | -48.96M | -42.21M | -43.27M | -36.94M | -32.23M | -39.34M | -241.08M |
| Consolidated Net IncomeConsol Net Inc. | -7.57M | -6.48M | -6.68M | -9.07M | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M | -41.02M | -56.33M | -48.96M | -42.21M | -43.27M | -36.94M | -32.23M | -39.34M | -241.08M |
| Income towards Parent CompanyParent Net Inc | -7.57M | -6.48M | -6.68M | -9.07M | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M | -41.02M | -56.33M | -48.96M | -42.21M | -43.27M | -36.94M | -32.23M | -39.34M | -241.08M |
| Net Income towards Common StockholdersNet Income | -7.57M | -6.48M | -6.68M | -9.07M | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M | -41.02M | -56.33M | -48.96M | -42.21M | -43.27M | -36.94M | -32.23M | -39.34M | -241.08M |
| Additional items | ||||||||||||||||||
| EPS (Basic) | -1.48 | -1.26 | -1.29 | -1.76 | -0.51 | -0.31 | -0.57 | -0.67 | -0.70 | -0.83 | -1.13 | -1.01 | -0.79 | -0.66 | -0.52 | -0.48 | -0.47 | -2.85 |
| EPS (Diluted) | -1.48 | -1.26 | -1.29 | -1.76 | -0.51 | -0.31 | -0.57 | -0.67 | -0.70 | -0.83 | -1.13 | -1.01 | -0.79 | -0.66 | -0.52 | -0.48 | -0.47 | -2.85 |
| Shares Outstanding | 5.12M | 5.15M | 5.18M | 5.17M | 24.76M | 39.75M | 39.93M | 36.19M | 44.90M | 49.36M | 49.82M | 48.54M | 53.16M | 65.45M | 70.59M | 67.66M | 82.83M | 84.73M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 5.12M | 5.15M | 5.18M | 5.17M | 24.76M | 39.75M | 39.93M | 36.19M | 44.90M | 49.36M | 49.82M | 48.54M | 53.16M | 65.45M | 70.59M | 67.66M | 82.83M | 84.73M |
| EBITDA | -7.57M | -6.48M | -7.42M | -10.01M | -14.94M | -15.73M | -26.27M | -27.71M | -35.36M | -45.17M | -60.11M | -51.77M | -44.45M | -46.75M | -41.13M | -38.28M | -45.34M | -246.04M |